Physician profile
Mary T Desane
NPI 1497058275
$1,891.40
in general payments reported to CMS, 2019-2025
8 companies · $314 in 2025
The $314 reported for 2025 was more than what 78% of Psychiatric/Mental Health, Adult (Registered Nurse) providers received nationally (typical 2025 total: $121).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $505 · 2022: $437 · 2023: $337 · 2024: $298 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.47 |
| Education | $101.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $989.41 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $379.51 | 2021-2025 | Austedo Xr |
| Alkermes, INC. | $278.50 | 2021-2024 | Lybalvi, Aristada |
| Abbvie INC. | $159.22 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $31.65 | 2022-2023 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $24.22 | 2021 | |
| Noven Therapeutics, LLC | $15.00 | 2022 | |
| Lundbeck LLC | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Desane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.